Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity

D. Lecis, M. De Cesare, P. Perego, A. Conti, E. Corna, C. Drago, P. Seneci, H. Walczak, M. P. Colombo, D. Delia, S. Sangaletti

Research output: Contribution to journalArticle


Smac mimetics (SMs) comprise a class of small molecules that target members of the inhibitor of apoptosis family of pro-survival proteins, whose expression in cancer cells hinders the action of conventional chemotherapeutics. Herein, we describe the activity of SM83, a newly synthesised dimeric SM, in two cancer ascites models: athymic nude mice injected intraperitoneally with IGROV-1 human ovarian carcinoma cells and immunocompetent BALB/c mice injected with murine Meth A sarcoma cells. SM83 rapidly killed ascitic IGROV-1 and Meth A cells in vivo (prolonging mouse survival), but was ineffective against the same cells in vitro. IGROV-1 cells in nude mice were killed within the ascites by a non-apoptotic, tumour necrosis factor (TNF)-dependent mechanism. SM83 administration triggered a rapid inflammatory event characterised by host secretion of TNF, interleukin-1β and interferon-γ. This inflammatory response was associated with the reversion of the phenotype of tumour-associated macrophages from a pro-tumoural M2- to a pro-inflammatory M1-like state. SM83 treatment was also associated with a massive recruitment of neutrophils that, however, was not essential for the antitumoural activity of this compound. In BALB/c mice bearing Meth A ascites, SM83 treatment was in some cases curative, and these mice became resistant to a second injection of cancer cells, suggesting that they had developed an adaptive immune response. Altogether, these results indicate that, in vivo, SM83 modulates the immune system within the tumour microenvironment and, through its pro-inflammatory action, leads cancer cells to die by necrosis with the release of high-mobility group box-1. In conclusion, our work provides evidence that SMs could be more therapeutically active than expected by stimulating the immune system.

Original languageEnglish
Article numbere920
JournalCell Death and Disease
Issue number11
Publication statusPublished - Nov 2013


  • IAPs
  • Inflammation
  • Innate immunity
  • Ovarian cancer ascites
  • Smac mimetics

ASJC Scopus subject areas

  • Cell Biology
  • Immunology
  • Cancer Research
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity'. Together they form a unique fingerprint.

  • Cite this

    Lecis, D., De Cesare, M., Perego, P., Conti, A., Corna, E., Drago, C., Seneci, P., Walczak, H., Colombo, M. P., Delia, D., & Sangaletti, S. (2013). Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity. Cell Death and Disease, 4(11), [e920].